The Latest: Trial of arthritis drug for COVID-19 is halted
|
January 20, 2021 4:03 PM
LONDON — An arthritis drug tried in patients with severe COVID-19 showed no benefit in a study that was stopped early because of safety concerns. The study was published Wednesday in the British journal The BMJ.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
